Puro V, De Carli G, Scognamiglio P, Porcasi R, Ippolito G
Dipartimento di Epidemiologia, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani-IRCCS, Rome, Italy.
Ann N Y Acad Sci. 2001 Nov;946:291-309. doi: 10.1111/j.1749-6632.2001.tb03918.x.
Health care workers (HCWs) face a well-recognized risk of acquiring blood-borne pathogens in their workplace, in particular hepatitis B and C viruses (HBV/HBC) and human immunodeficiency virus (HIV). Additionally, infected HCWs performing invasive exposure-prone procedures, including in the cardiac setting, represent a potential risk for patients. An increasing number of infected persons could need specific cardiac diagnostic procedures and surgical treatment in the future, regardless of their sex or age. The risk of acquiring HIV, HCV, HBV infection after a single at-risk exposure averages 0.5%, and 1-2%, and 4-30%, respectively. The frequency of percutaneous exposure ranges from 1 to 15 per 100 surgical interventions, with cardiothoracic surgery reporting the highest rates of exposures; mucocutaneous contamination by blood-splash occurs in 50% of cardiothoracic operations. In the Italian Surveillance (SIROH), a total of 987 percutaneous and 255 mucocutaneous exposures were reported in the cardiac setting; most occurred in cardiology units (46%), and in cardiovascular surgery (44%). Overall, 257 source patients were anti-HCV+, 54 HBsAg+, and 14 HIV+. No seroconversions were observed. In the literature, 14 outbreaks were reported documenting transmission of HBV from 12 infected HCWs to 107 patients, and 2 cases of HCV to 6 patients, during cardiothoracic surgery, especially related to sternotomy and its suturing. The transmission rate was estimated to be 5% to 13% for HBV, and 0.36% to 2.25% for HCV. Strategies in risk reduction include adequate surveillance, education, effective sharps disposal, personal protective equipment, safety devices, and innovative technology-based intraoperative procedures.
医护人员(HCWs)在工作场所面临着公认的感染血源性病原体的风险,尤其是乙型和丙型肝炎病毒(HBV/HBC)以及人类免疫缺陷病毒(HIV)。此外,受感染的医护人员进行包括心脏手术在内的有创易暴露操作时,会给患者带来潜在风险。未来,越来越多的感染者可能需要进行特定的心脏诊断程序和手术治疗,无论其性别或年龄如何。单次高危暴露后感染HIV、HCV、HBV的风险平均分别为0.5%、1 - 2%和4 - 30%。经皮暴露的频率为每100例手术干预中有1至15次,心胸外科手术的暴露率最高;50%的心胸手术会发生血液飞溅导致的黏膜皮肤污染。在意大利监测系统(SIROH)中,心脏手术环境下共报告了987次经皮暴露和255次黏膜皮肤暴露;大多数发生在心脏病科(46%)和心血管外科(44%)。总体而言,257名源患者抗HCV呈阳性,54名HBsAg呈阳性,14名HIV呈阳性。未观察到血清转化。在文献中,报告了14起疫情,记录了在心胸外科手术期间,12名受感染医护人员将HBV传播给107名患者,以及2例HCV传播给6名患者情况,尤其与胸骨切开术及其缝合有关。HBV的传播率估计为5%至13%,HCV为0.36%至2.25%。降低风险的策略包括充分的监测、教育、有效的锐器处理、个人防护设备、安全装置以及基于创新技术的术中操作。